NewEdge Advisors’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.37K Hold
400
﹤0.01% 3966
2026
Q1
$912 Sell
400
-300
-43% -$691 ﹤0.01% 3915
2025
Q4
$1.96K Sell
700
-2,500
-78% -$8.94K ﹤0.01% 3894
2025
Q3
$15.4K Sell
3,200
-600
-16% -$3.82K ﹤0.01% 3209
2025
Q2
$34.6K Buy
3,800
+45
+1% +$332 ﹤0.01% 2774
2025
Q1
$33.9K Sell
3,755
-1,025
-21% -$10.8K ﹤0.01% 2679
2024
Q4
$62.5K Buy
4,780
+610
+15% +$8.13K ﹤0.01% 2446
2024
Q3
$65.4K Sell
4,170
-600
-13% -$9.09K ﹤0.01% 2349
2024
Q2
$64.4K Buy
4,770
+225
+5% +$4.61K ﹤0.01% 2264
2024
Q1
$126K Sell
4,545
-50
-1% -$1.11K ﹤0.01% 1999
2023
Q4
$88.6K Hold
4,595
﹤0.01% 1994
2023
Q3
$74.3K Sell
4,595
-75
-2% -$1.33K ﹤0.01% 1948
2023
Q2
$88.9K Buy
4,670
+195
+4% +$3.48K ﹤0.01% 1888
2023
Q1
$65.1K Sell
4,475
-1,001
-18% -$17.9K ﹤0.01% 1894
2022
Q4
$19.6K Buy
+5,476
New +$107K ﹤0.01% 2127
2017
Q3
Sell
-487
Closed -$15.5K 878
2017
Q2
$15.5K Buy
+487
New +$16K ﹤0.01% 816

Other funds holding ACH

NewEdge Advisors's ACH Position: Q2 2026 in Review

NewEdge Advisors held its Accendra Health (ACH) position steady in Q2 2026 at 400 shares worth $1.37K. The position accounts for ﹤0.01% of the portfolio, ranked #3966.

NewEdge Advisors first reported a position in ACH in Q2 2017 and has held it in 16 quarters since. The position peaked at $126K in Q1 2024. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • NewEdge Advisors held 400 shares of Accendra Health worth $1.37K as of Q2 2026.
  • NewEdge Advisors left its Accendra Health share count unchanged in Q2 2026.
  • Accendra Health made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #3966 holding.
  • NewEdge Advisors first reported a position in Accendra Health in Q2 2017 and has held it in 16 quarters since.
  • NewEdge Advisors's Accendra Health position peaked at $126K in Q1 2024.
  • 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.